![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61P 11/00 | (2018.01) |
A61K 9/12 | (2006.01) | ||
A61K 9/14 | (2006.01) | ||
Y10T 428/2982 | (2015.01) | ||
C08B 37/16 | (2006.01) | ||
A61P 29/00 | (2018.01) | ||
A61K 47/40 | (2006.01) | ||
A61P 11/06 | (2018.01) | ||
A61P 5/40 | (2006.01) | ||
A61P 37/08 | (2018.01) | ||
A61P 11/00 | (2006.01) | ||
A61P 5/40 | (2018.01) | ||
A61P 11/06 | (2006.01) | ||
A61K 9/0075 | (2013.01) | ||
A61P 29/00 | (2006.01) | ||
A61P 43/00 | (2018.01) | ||
A61K 47/40 | (2013.01) | ||
A61P 37/08 | (2006.01) | ||
A61P 43/00 | (2006.01) |
(11) | Number of the document | 3520779 |
(13) | Kind of document | T |
(96) | European patent application number | 18214449.3 |
Date of filing the European patent application | 2005-04-22 | |
(97) | Date of publication of the European application | 2019-08-07 |
(45) | Date of publication and mention of the grant of the patent | 2021-12-22 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
56489204 P | 2004-04-23 | US |
(72) |
PIPKIN, James D , US
MOSHER, Gerold L. , US
HECKER, Douglas B , US
|
(73) |
CyDex Pharmaceuticals, Inc. ,
5980 Horton Street
Suite 405, Emeryville, CA 94608,
US
|
(54) | DPI FORMULATION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN |
DPI FORMULATION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN |